While there's no definitive cure for Multiple Sclerosis (MS) expected within the next 10 years, significant progress in disease-modifying therapies (DMTs) is drastically improving quality of life, slowing progression, and preventing relapses, with research focused on nerve repair and regeneration offering strong hope for eventual cures, possibly within a lifetime for many, says the UC San Francisco and MS Australia.
There is no cure for multiple sclerosis (MS). However, progress has been made in developing new medicines to treat it. Research is ongoing to develop new and better disease-modifying therapies (DMTs) for this disease of the central nervous system. DMTs can reduce the frequency and severity of MS attacks.
At least 20% to 40% of people with relapsing-remitting multiple sclerosis can eventually develop a steady progression of symptoms. This progression may come with or without periods of remission and happens within 10 to 40 years of disease onset. This is known as secondary-progressive MS.
You may experience an uncomfortable squeezing sensation known as the MS hug. If you have pain on the side of your face or something that feels like earache or toothache, we call this trigeminal neuralgia. Other pain can come from muscle spasms or if your MS impacts your posture.
Multiple sclerosis therapy can 'reverse disease' The high-risk treatment reversed the symptoms of some patients in a trial, but the therapy is not suitable for all MS sufferers. A radical treatment can halt the progression of multiple sclerosis and even reverse symptoms of the autoimmune disease, research suggests.
Although MS cannot yet be fully cured, early diagnosis and treatment slow down its progression, reduce relapses and help maintain quality of life.
The exact trigger for Multiple Sclerosis (MS) is unknown, but it's believed to be a combination of genetic predisposition and environmental factors, including certain infections (like Epstein-Barr Virus), low Vitamin D levels (linked to less sunlight), smoking, obesity, stress, and potentially genetic susceptibility. These factors can trigger an autoimmune attack where the immune system mistakenly damages myelin in the central nervous system.
Some people with MS lose sensation in their tongue. Some health care providers refer to MS-related tongue issues as “MS tongue.” Loss of sensation or numbness can make it difficult to move your tongue when you speak, chew, or swallow. Tongue numbness may also diminish sense of taste.
1800 mg of Gabapentin a day is a common dose to help neuropathic pain. The FDA has approved PreGabalin and Cymbalta for treatment of diabetic related peripheral neuropathic pain and fibromyalgia, but we also use these medications for MS neuropathic pain in an off label fashion.
If your MS symptoms feel worse at night, you are not alone. Many people find their MS is worse or harder to cope with at night time. It can disrupt your sleep and play havoc with your energy levels, concentration and emotions the next day.
Stress does not directly cause multiple sclerosis (MS), but it may trigger symptoms or relapses in people who already have the condition. Many people with MS report that their first symptoms appeared during or after a period of significant stress or trauma, which has led to ongoing discussion about a possible link.
For those with MS, avoiding too much exercise is a big concern. Too much activity can cause fatigue and worsen symptoms. It's important to listen to your body and know when you've done too much. Pacing activities and taking breaks helps manage energy.
The ageing brain
As we age, our brain's ability to adapt and reroute messages around areas of MS nerve damage (known as neuroplasticity) gradually reduces. This can contribute to reduced recovery from relapses and the increasing disability we see in progressive MS.
Take, for example, these six diseases that may be cured within our lifetime.
Tolebrutinib was provisionally approved in the United Arab Emirates in July 2025 for the treatment of non-relapsing secondary progressive multiple sclerosis and to slow disability accumulation independent of relapse activity in adults. It is currently under regulatory review in the EU and other jurisdictions worldwide.
A small number of people with MS will have mild symptoms with little disability, but others will experience worsening symptoms that will lead to increased disability over time. Most people with MS have short periods of symptoms that resolve fully or partially after they appear.
To stop nerve pain immediately, topical lidocaine or capsaicin creams/patches can provide quick numbing relief, while prescription options like anti-seizure drugs (gabapentin) or strong painkillers (tramadol) offer faster but not always instant relief; gentle stretches, TENS, and relaxation techniques can also help manage acute flare-ups by blocking pain signals or relaxing muscles.
MS Symptoms in Legs
Numbness or Tingling: A “pins and needles” sensation, or complete numbness, often starting in the feet and moving upward. Spasticity (Muscle Stiffness or Spasms): Tight or rigid muscles that make walking or bending the legs difficult. Muscle spasms, especially in the calves, are also common.
Heightened risk of tooth decay (dental caries) and gum disease (gingivitis and periodontitis) are among the chief multiple sclerosis dental considerations.
MS-related itching can happen anywhere on the body and can affect one or both sides. It most commonly affects the face, torso, arms, and legs.
Personal Independence Payment (PIP)
You can spend it on whatever you need, such as paying for support to remain independent during relapses, or to help with extra costs such as heating, transport or help around the house. Some people with MS assume they can't get PIP because they're 'not disabled enough'.
The exact cause of MS is unknown but there are some things that could increase your risk of getting MS. Age, genetics, biological sex, obesity and smoking play a role. Things connected to your environment like infections and vitamin D levels can also play a part.
Can stress cause MS? Some people with MS believe they developed MS as a direct result of a stressful event or trauma in their life. But the evidence for any link isn't clear cut. Some studies do suggest an effect whilst others don't.
History of the EBV-MS Connection
The link between MS and EBV was noted as early as the 1980s. Numerous studies have confirmed that more than 99% of patients with MS have been infected with EBV, which is significantly higher than the 90–95% seroprevalence in the global population.